Filing metadata

Accession number
0001415889-24-008973
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Mar 22, 2024
Reporting period
Mar 20, 2024
Description
Insider transaction

Explore SEC Filings Hub